Matches in Wikidata for { <http://www.wikidata.org/entity/Q37381593> ?p ?o ?g. }
- Q37381593 description "article científic" @default.
- Q37381593 description "article scientifique" @default.
- Q37381593 description "articolo scientifico" @default.
- Q37381593 description "artigo científico" @default.
- Q37381593 description "artículu científicu espublizáu en 2013" @default.
- Q37381593 description "bilimsel makale" @default.
- Q37381593 description "scientific article published on October 2013" @default.
- Q37381593 description "vedecký článok" @default.
- Q37381593 description "vetenskaplig artikel" @default.
- Q37381593 description "videnskabelig artikel" @default.
- Q37381593 description "vědecký článek" @default.
- Q37381593 description "wetenschappelijk artikel" @default.
- Q37381593 description "wissenschaftlicher Artikel" @default.
- Q37381593 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q37381593 description "научни чланак" @default.
- Q37381593 description "مقالة علمية نشرت في أكتوبر 2013" @default.
- Q37381593 name "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 name "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 name "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 type Item @default.
- Q37381593 label "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 label "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 label "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 prefLabel "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 prefLabel "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 prefLabel "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 P1433 Q37381593-C3ED3F61-A244-43D1-9045-97D90B570F58 @default.
- Q37381593 P1476 Q37381593-BE6735E8-EFDB-4FD3-9248-D277C879E8BE @default.
- Q37381593 P2093 Q37381593-718D665A-F22B-497B-80EB-0FF069F2EB39 @default.
- Q37381593 P2093 Q37381593-72E8F246-7DB5-4115-8ED5-ED099BA586EB @default.
- Q37381593 P2093 Q37381593-7CA77F84-29B7-44A8-A7F3-1C6D720C8838 @default.
- Q37381593 P2093 Q37381593-816738A8-E013-466C-9377-911A438F59AE @default.
- Q37381593 P2093 Q37381593-94075AF3-DEEB-4F26-9782-93520C9A1BD1 @default.
- Q37381593 P2093 Q37381593-9DC86710-0443-4A51-A8C0-116D0FB1EBE2 @default.
- Q37381593 P2093 Q37381593-A03EEF8F-354C-473B-B6D3-A5DFB3F5363F @default.
- Q37381593 P2860 Q37381593-0C9158FC-4192-4112-89A0-BD92AA4D6926 @default.
- Q37381593 P2860 Q37381593-0CCB6B5B-2FDA-441B-82BC-638CF7197028 @default.
- Q37381593 P2860 Q37381593-163A560C-49AC-4008-8B74-99263E36B273 @default.
- Q37381593 P2860 Q37381593-195B1E48-EE48-41A1-9A1B-8072EFFBB042 @default.
- Q37381593 P2860 Q37381593-19EE0F09-77C9-4E35-A1E5-272E1AC061CA @default.
- Q37381593 P2860 Q37381593-1B34EF4D-9DA7-4614-9157-5C01FD22CAF5 @default.
- Q37381593 P2860 Q37381593-3A27FEC2-EE66-40A2-A44E-CD8E97BB2C77 @default.
- Q37381593 P2860 Q37381593-3D607190-D692-4383-BC5E-DED2B3A5E6BE @default.
- Q37381593 P2860 Q37381593-42963A70-1379-436F-B89D-FDFB99D1BC0C @default.
- Q37381593 P2860 Q37381593-5268C926-44C6-4883-B106-FB0B22E4C60F @default.
- Q37381593 P2860 Q37381593-71645ACA-1A20-416E-971A-A28E8F7F7584 @default.
- Q37381593 P2860 Q37381593-78AFBFDF-CFB0-4111-9487-39C0C6E56FE3 @default.
- Q37381593 P2860 Q37381593-922CA545-B177-465F-80F9-2943E24E91F9 @default.
- Q37381593 P2860 Q37381593-93512663-078E-4F5B-A911-F98AD14E0149 @default.
- Q37381593 P2860 Q37381593-9A54F347-5D95-4F1F-B135-7EFD6103D01F @default.
- Q37381593 P2860 Q37381593-9A5BE15B-BFBC-435E-87C4-0031F1D16732 @default.
- Q37381593 P2860 Q37381593-A42C6F83-57BA-455C-9195-A647535795CB @default.
- Q37381593 P2860 Q37381593-A9053B7E-A61F-434D-9D16-E12AC38EA33C @default.
- Q37381593 P2860 Q37381593-A99853D3-45F6-42B2-BCED-5D0BC6970A5E @default.
- Q37381593 P2860 Q37381593-AB121AB6-6904-461D-9F93-C42B00C8C177 @default.
- Q37381593 P2860 Q37381593-ADC4271A-65E0-421C-BB6C-277551655D1F @default.
- Q37381593 P2860 Q37381593-BDF867C9-CC3D-4839-BE9C-A0EAB7975A46 @default.
- Q37381593 P2860 Q37381593-BE36B2D5-3AA7-4587-9C8F-CCA272041DE0 @default.
- Q37381593 P2860 Q37381593-C215C6B2-33CC-4FB8-A9FE-CD25D48D4A28 @default.
- Q37381593 P2860 Q37381593-C6BE8FDB-4914-4490-9C24-F7E4E24BDF9F @default.
- Q37381593 P2860 Q37381593-C6C9C899-0EA9-4DC0-869E-E5515B56D25F @default.
- Q37381593 P2860 Q37381593-CFA59DEC-0476-4241-9842-A30FDDAE4F2E @default.
- Q37381593 P2860 Q37381593-D6AC6AF9-8E45-4415-A527-C7A5CE821BD8 @default.
- Q37381593 P2860 Q37381593-D8BDA90F-93ED-40D3-8B7C-6981A96B36F7 @default.
- Q37381593 P2860 Q37381593-F8A72186-BC5C-4AEF-90F5-CB3BB60371CF @default.
- Q37381593 P2860 Q37381593-F9EEB0F7-CC81-48D9-955E-C8EB97A03CDB @default.
- Q37381593 P2860 Q37381593-FB988739-416D-4765-B9AC-B030A15AA4EE @default.
- Q37381593 P304 Q37381593-04168B1E-9249-4C55-8667-CEDF4FEF8608 @default.
- Q37381593 P31 Q37381593-0CE31F74-54B2-433C-95E3-987F29E75B51 @default.
- Q37381593 P356 Q37381593-5C03A1E3-A61C-4700-BCA6-A19AF40223E3 @default.
- Q37381593 P407 Q37381593-65A0D002-25D5-41DE-9573-F7BDD8EF0D78 @default.
- Q37381593 P433 Q37381593-CB106907-1044-47F3-9808-ED86B0CC8383 @default.
- Q37381593 P478 Q37381593-2833B6E0-2D0E-4970-BA1D-EBBAE1E839AA @default.
- Q37381593 P50 Q37381593-E9D0D556-4FF8-48ED-9D36-FC60F481F04F @default.
- Q37381593 P577 Q37381593-C4FCBE69-7489-49B6-83D7-30E8E2236C20 @default.
- Q37381593 P5875 Q37381593-D5BA9D3D-43D8-4235-824B-AF40EAEDA6D2 @default.
- Q37381593 P698 Q37381593-467DA3C7-A570-4B00-B049-42AA379D6398 @default.
- Q37381593 P921 Q37381593-94C3CC63-A2CA-4E01-83B7-F08CA210BC44 @default.
- Q37381593 P932 Q37381593-D8056839-5366-4CC9-B4D3-0E3DFAD9FEE7 @default.
- Q37381593 P356 ONCOTARGET.1232 @default.
- Q37381593 P698 24091566 @default.
- Q37381593 P1433 Q1573155 @default.
- Q37381593 P1476 "HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma" @default.
- Q37381593 P2093 "Aaron M Gruver" @default.
- Q37381593 P2093 "Bryce P Portier" @default.
- Q37381593 P2093 "Christopher Lanigan" @default.
- Q37381593 P2093 "Eugen C Minca" @default.
- Q37381593 P2093 "G Thomas Budd" @default.
- Q37381593 P2093 "Raymond R Tubbs" @default.
- Q37381593 P2093 "Zhen Wang" @default.
- Q37381593 P2860 Q22253346 @default.
- Q37381593 P2860 Q24293729 @default.
- Q37381593 P2860 Q24314750 @default.
- Q37381593 P2860 Q27824766 @default.
- Q37381593 P2860 Q27860693 @default.
- Q37381593 P2860 Q33968565 @default.
- Q37381593 P2860 Q35012797 @default.
- Q37381593 P2860 Q35195417 @default.
- Q37381593 P2860 Q35586732 @default.
- Q37381593 P2860 Q35633712 @default.